Galectin-9 Activates and Expands Human T-Helper 1 Cells

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Gooden, Marloes J M ^a   Wiersma, Valerie R ^a   Samplonius, Douwe F ^a   Gerssen, Jurjen ^a   van Ginkel, Robert J ^a   Nijman, Hans W ^a   Hirashima, Mitsuomi ^b,c   Niki, Toshiro ^b,c   Eggleton, Paul ^d   Helfrich, Wijnand ^a   Bremer, Edwin ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Galpharma Co Ltd   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

^d UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; ECALECTIN; GAMMA INTERFERON; INTERLEUKIN 2;

APOPTOSIS; ARTICLE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CELL DIVISION; CELL EXPANSION; CELL SURVIVAL; CELL VIABILITY; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MEMORY T LYMPHOCYTE; PERIPHERAL LYMPHOCYTE; PHASE TRANSITION; PHENOTYPE; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

CD4-POSITIVE T-LYMPHOCYTES; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; GALECTINS; HUMANS; IMMUNOLOGIC MEMORY; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, HELPER-INDUCER;

MURINAE;

EID: 84878621977     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065616     Document Type: Article

References (35)

1. Kishore U, Eggleton P, Reid KB, (1997) Modular organization of carbohydrate recognition domains in animal lectins. Matrix Biol 15: 583-592.
2. Wiersma VR, de Bruyn M, Helfrich W, Bremer E, (2013) Therapeutic potential of Galectin-9 in human disease. Med Res Rev 33: E102-E126.
3. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, et al. (2005) The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6: 1245-1252.
4. Kashio Y, Nakamura K, Abedin MJ, Seki M, Nishi N, et al. (2003) Galectin-9 Induces Apoptosis Through the Calcium-Calpain-Caspase-1 Pathway. J Immunol 170: 3631-3636.
5. Wang F, Xu J, Liao Y, Wang Y, Liu C, et al. (2011) Tim-3 ligand galectin-9 reduces IL-17 level and accelerates Klebsiella pneumoniae infection. Cellular Immunol 269: 22-28.
6. Oomizu S, Arikawa T, Niki T, Kadowaki T, Ueno M, et al. (2012) Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. Clin Immunol 143: 51-58.
7. Bi S, Earl LA, Jacobs L, Baum LG, (2008) Structural Features of Galectin-9 and Galectin-1 That Determine Distinct T Cell Death Pathways. J Biol Chem 283: 12248-12258.
8. Wang F, Wan L, Zhang C, Zheng X, Li J, Chen ZK, (2009) Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. Immunobiology 214: 342-349.
9. Seki M, Oomizu S, Sakata KM, Sakata A, Arikawa T, et al. (2008) Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 127: 78-88.
10. Chou FC, Shieh SJ, Sytwu HK, (2009) Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur J Immunol 39: 2403-2411.
11. Kanzaki M, Wada J, Sugiyama K, Nakatsuka A, Teshigawara S, et al. (2012) Galectin-9 and T Cell Immunoglobulin Mucin-3 Pathway Is a Therapeutic Target for Type 1 Diabetes. Endocrinology 153: 612-620.
12. Nagahara K, Arikawa T, Oomizu S, Kontani K, Nobumoto A, et al. (2008) Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions. J Immunol 181: 7660-7669.
13. de Kivit S, Saeland E, Kraneveld AD, van de Kant HJ, Schouten B, et al. (2012) Galectin-9 induced by dietary synbiotics is involved in suppression of allergic symptoms in mice and humans. Allergy 67: 343-352.
14. Anderson AC, (2012) Tim-3, a negative regulator of anti-tumor immunity. Curr Opin Immunol 24: 213-216.
15. Su EW, Bi S, Kane LP, (2011) Galectin-9 regulates T helper cell function independently of Tim-3. Glycobiology 21: 1258-1265.
16. Bi S, Hong PW, Lee B, Baum LG, (2011) Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry. Proc Natl Acad Sci U S A 108: 10650-10655.
17. Elahi S, Niki T, Hirashima M, Horton H, (2012) Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection. Blood 119: 4192-4204.
18. Vaitaitis GM, Wagner DH Jr (2012) Galectin-9 controls CD40 signaling through a Tim-3 independent mechanism and redirects the cytokine profile of pathogenic T cells in autoimmunity. PLoS One 7:e38708
19. Arikawa T, Watanabe K, Seki M, Matsukawa A, Oomizu S, et al. (2009) Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages. Clin Immunol 133: 382-392.
20. Nishi N, Itoh A, Fujiyama A, Yoshida N, Araya S, et al. (2005) Development of highly stable galectins: Truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins. FEBS Lett 579: 2058-2064.
21. Bremer E, Abdulahad WH, de Bruyn M, Samplonius DF, Kallenberg CG, et al. (2011) Selective elimination of pathogenic synovial fluid T-cells from Rheumatoid Arthritis and Juvenile Idiopathic Arthritis by targeted activation of Fas-apoptotic signaling. Immunol Lett 138: 161-168.
22. Zhou Q, Munger ME, Veenstra RG, Weigel BJ, Hirashima M, et al. (2011) Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia. Blood 117: 4501-4510.
23. Lu LH, Nakagawa R, Kashio Y, Ito A, Shoji, et al, (2007) Characterization of galectin-9-induced death of Jurkat T cells. J Biochem 141: 157-172.
24. Wada J, Ota K, Kumar A, Wallner EI, Kanwar YS, (1997) Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J Clin Invest 99: 2452-2461.
25. Nobumoto A, Oomizu S, Arikawa T, Katoh S, Nagahara K, et al. (2009) Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice. Clin Immunol 130: 322-330.
26. Katoh S, Ishii N, Nobumoto A, Takeshita K, Dai SY, et al. (2007) Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am J Respir Crit Care Med 176: 27-35.
27. Niki T, Tsutsui S, Hirose S, Aradono S, Sugimoto Y, et al. (2009) Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation. J Biol Chem 284: 32344-32352.
28. Palacios R, (1982) Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation. J Immunol 128: 337-342.
29. Walzel H, Blach M, Hirabayashi J, Kasai KI, Brock J, (2000) Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells. Glycobiology 10: 131-140.
30. Dai SY, Nakagawa R, Itoh A, Murakami H, Kashio Y, et al. (2005) Galectin-9 induces maturation of human monocyte-derived dendritic cells. J Immunol 175: 2974-2981.
31. Gleason MK, Lenvik TR, McCullar V, Felices M, O'Brien MS, et al. (2012) Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9. Blood 119: 3064-3072.
32. Lv K, Xu W, Wang C, Niki T, Hirashima M, et al. (2011) Galectin-9 administration ameliorates CVB3 induced myocarditis by promoting the proliferation of regulatory T cells and alternatively activated Th2 cells. Clin Immunol 140: 92-101.
33. Shim JA, Park S, Lee ES, Niki T, Hirashima M, et al. (2012) Galectin-9 ameliorates herpes simplex virus-induced inflammation through apoptosis. Immunobiology 217: 657-666.
34. Kurose Y, Wada J, Kanzaki M, Teshigawara S, Nakatsuka A, et al. (2013) Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease. BMC Nephrol 14: 23.
35. Moon JY, Jeong KH, Lee TW, Ihm CG, Lim SJ, et al. (2012) Aberrant recruitment and activation of T cells in diabetic nephropathy. AM J Nephrol 35: 164-174.